Studying the Dose Response of 50 and 100 IU of Botox A Toxin Injection in the Prostates of BPH Patients.
Phase of Trial: Phase 0
Latest Information Update: 22 Feb 2017
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 22 Feb 2017 Last checked against ClinicalTrials.gov record.
- 17 Feb 2017 Status changed from recruiting to completed.
- 28 Jan 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.